AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment ...

The New Hampshire Department of Health and Human Services (DHHS) said a person from Merrimack County has become the first ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...

AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

International researchers have engineered protein-based nanomachines that detect lanthanides, offering new methods for rare ...

Flies circulating in hospital wards may pose a threat to vulnerable patients by spreading bacteria that are resistant to ...

Australian synthetic biologists have developed a prototype for an innovative biosensor that can detect rare earth elements ...

Most studies evaluating combinations of macrolides and beta-lactamase antibiotics or beta-lactamase agents used alone (eg, ampicillin) did not show benefit. A single study using metronidazole ...